RU2013109455A - TRANSDERMAL AGENT CONTAINING SILICON-ORGANIC NATURE NANOCONTAINERS FOR TREATMENT OF PSYCHO-EMOTIONAL DISORDERS - Google Patents
TRANSDERMAL AGENT CONTAINING SILICON-ORGANIC NATURE NANOCONTAINERS FOR TREATMENT OF PSYCHO-EMOTIONAL DISORDERS Download PDFInfo
- Publication number
- RU2013109455A RU2013109455A RU2013109455/15A RU2013109455A RU2013109455A RU 2013109455 A RU2013109455 A RU 2013109455A RU 2013109455/15 A RU2013109455/15 A RU 2013109455/15A RU 2013109455 A RU2013109455 A RU 2013109455A RU 2013109455 A RU2013109455 A RU 2013109455A
- Authority
- RU
- Russia
- Prior art keywords
- nanocontainers
- psycho
- treatment
- agent containing
- containing silicon
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Abstract
Седативное трансдермальное средство, включающее растительные экстракты, отличающееся тем, что экстракты инкапсулированы в кремнийорганические наноконтейнеры с 10% содержанием в геле, а экстракты пустырника, зверобоя гинкго билоба в соотношении 1:1.Sedative transdermal product, including plant extracts, characterized in that the extracts are encapsulated in organosilicon nanocontainers with a 10% gel content, and motherwort, St. John's wort ginkgo biloba extracts in a 1: 1 ratio.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2013109455/15A RU2560668C2 (en) | 2013-03-04 | 2013-03-04 | Transdermal sedative pharmaceutical gel for treatment of psychoemotional disorders |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2013109455/15A RU2560668C2 (en) | 2013-03-04 | 2013-03-04 | Transdermal sedative pharmaceutical gel for treatment of psychoemotional disorders |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2013109455A true RU2013109455A (en) | 2014-09-10 |
RU2560668C2 RU2560668C2 (en) | 2015-08-20 |
Family
ID=51539813
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2013109455/15A RU2560668C2 (en) | 2013-03-04 | 2013-03-04 | Transdermal sedative pharmaceutical gel for treatment of psychoemotional disorders |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2560668C2 (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI389709B (en) * | 2005-12-01 | 2013-03-21 | Novartis Ag | Transdermal therapeutic system |
RU2408384C2 (en) * | 2006-04-19 | 2011-01-10 | Джианксан ЛЬЮ | Chinese medicinal composition, method for preparing and administration |
RU2383328C2 (en) * | 2007-07-02 | 2010-03-10 | Общество с ограниченной ответственностью Научно-производственное объединение "Клеточные технологии" | Transdermal gel for area around eyes "silky touch" |
RU2391996C1 (en) * | 2008-12-22 | 2010-06-20 | Ольга Александровна Субботина | Remedy for treatment of cardiovascular diseases |
-
2013
- 2013-03-04 RU RU2013109455/15A patent/RU2560668C2/en active IP Right Revival
Also Published As
Publication number | Publication date |
---|---|
RU2560668C2 (en) | 2015-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3686200A3 (en) | Bicyclic heterocycle compounds and their uses in therapy | |
EA201391119A1 (en) | DELIVERY SYSTEMS OF NANOPARTICLES, THEIR RECEIVING AND APPLICATION | |
UA109650C2 (en) | BIS-ARLYZED ARILTRIAZOLONS AND THEIR APPLICATIONS | |
WO2015048689A8 (en) | Inhibitors of bruton's tyrosine kinase | |
MA38399A1 (en) | Formulation in tablet form, useful for treating acute heart failure and chronic heart failure | |
MX2015009106A (en) | Solid solution compositions and use in severe pain. | |
PL2928484T3 (en) | Compounds useful in the treatment and/or care of the skin, hair and/or mucous membranes and their cosmetic or pharmaceutical compositions | |
PH12015502535A1 (en) | Process for the preparation of erythrocytes loaded with one or more substances of pharmaceutical interest and so obtained erythrocytes | |
NZ630367A (en) | Methods of treatment of pediatric solid tumor | |
FR3028753B1 (en) | AQUEOUS OR HYDRO-ALCOHOLIC GEL OF SYNTHETIC PHYLLOSILICATES AS A VISCOSING AGENT, MATIFIING AND / OR HOMOGENIZING APPLICATION | |
EA201591925A1 (en) | THERAPEUTIC COMPOSITIONS AND THEIR APPLICATION | |
EA201891608A1 (en) | DERIVATIVES OF 8-AMINO-2-OXO-1,3-DIAZASPIRO [4,5] DEAN | |
WO2015130554A3 (en) | Dosage and administration of anti-igf-1r, anti-erbb3 bispecific antibodies, uses thereof and methods of treatment therewith | |
TR201910866T4 (en) | Combined preparations for cancer treatment. | |
EA201491691A1 (en) | UNITS OF NANOPARTICLES CONTAINING OSTEOPONTIN AND CALCIUM AND / OR STRONTIUM PARTY | |
MA38253A1 (en) | Compositions comprising vortioxetine and donepezil | |
EA201891612A1 (en) | DERIVATIVES 3- (CARBOXYMETHYL) -8-AMINO-2-OXO-1,3-DIAZASPIRO [4.5] DEAN | |
MX2023007706A (en) | Nanoparticles for use as a therapeutic vaccine. | |
NZ745187A (en) | 3-(carboxyethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives | |
EA201891611A1 (en) | DERIVATIVES 3 - ((HETERO-) Aryl) -8-AMINO-2-OXO-1,3-DIAZASPIRO [4,5] DEAN | |
MA39447B1 (en) | Pirlindole or its pharmaceutically acceptable salts for use in medicine | |
MY177827A (en) | Combination of valerian root extract and lavender oil for use in the treatment of sleep disorders | |
MX2015013755A (en) | Pharmaceutical formulation for use in the treatment and/or prevention of restenosis. | |
CL2012003209A1 (en) | Synthesis method of poly (lactic-glycolic acid) nanoparticles (plga) with pentoxifylline; pharmaceutical composition comprising nanoparticles of pest with pentoxifylline; and use of the nanoparticles loaded with pentoxifylline in the treatment of relief and prevention of chronic pain. | |
TR201007110A2 (en) | Combinations with synergistic effects |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20151005 |
|
NF4A | Reinstatement of patent |
Effective date: 20170613 |
|
PD4A | Correction of name of patent owner | ||
PC41 | Official registration of the transfer of exclusive right |
Effective date: 20180206 |
|
QB4A | Licence on use of patent |
Free format text: LICENCE FORMERLY AGREED ON 20190301 Effective date: 20190301 |